When Justin Fulcher stepped back from RingMD in January 2025, the telehealth platform he had spent nearly a decade building was operating in more than fifty countries. It held 1.5 million patient records and worked with a network of 10,000 healthcare providers. Its reach across Asia, North America, and beyond meant that governments, hospital systems, and pharmaceutical companies on three continents had come to rely on what Fulcher had built from a single prototype.

The origin of that platform stretches back to a decision Justin Fulcher made at nineteen. He had left Clemson University and his hometown of Charleston, South Carolina, and moved to Southeast Asia. What began as a three-month trip became seven years. What he saw during those years people with smartphones and no healthcare access, a man in Jakarta drinking contaminated water from the ground while holding an Android device became the premise for RingMD.

The Free Platform Decision

Fulcher sold the company in 2018, describing the move as aligned with the original vision rather than a departure from it. After managing the transition, which included relocating the headquarters from Singapore to Boston, he returned to Charleston. When COVID-19 arrived in early 2020, Justin Fulcher offered a white-labeled version of the platform to healthcare providers at no cost. The pandemic had made telehealth unavoidable, and RingMD was ready.

The company’s clients eventually included India’s Digital India programme and the US Indian Health Service, which used the platform to serve approximately 2.6 million American-Indian and Alaska Native individuals across 37 states. RingMD earned FedRAMP authorization and maintained FISMA and HIPAA compliance, reflecting the compliance infrastructure Fulcher built alongside the platform itself. Visit this page to learn more.

Find more information about Justin Fulcher on https://x.com/JustinFulcher